N-Power Medicine

N-Power Medicine

Accelerates cancer therapy development for pharma

Overview

N-Power Medicine focuses on oncology-related drug development services. It accelerates the creation of cancer therapies by partnering with pharmaceutical companies and research institutions, leveraging advanced technologies and innovative methods to shorten development timelines and bring effective treatments to patients faster. The company’s services are delivered through collaborations, earning revenue from service fees, research grants, and potential licensing of its proprietary technologies. Compared with competitors, it emphasizes specialized oncology expertise, active partnerships, and a workflow that combines research services with opportunities for licensing, aiming to streamline development rather than just offer generic research support. The goal is to improve patient outcomes by speeding up the availability of effective cancer treatments.

About N-Power Medicine

Simplify's Rating
Why N-Power Medicine is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Merck partnership and $72M Series B funding enable rapid clinic network expansion.
  • Syapse acquisition integrates precision medicine capabilities into core trial platform.
  • 85% of cancer patients receive care in community settings, massive addressable market.

What critics are saying

  • Merck's lead investment concentrates revenue dependency, limiting pharma customer diversification.
  • Syapse integration delays operational execution and risks customer churn during transition.
  • FDA validation failure of AI-enabled research-ready data blocks biopharma partnerships entirely.

What makes N-Power Medicine unique

  • Always-on external control arm embedded in routine community oncology care workflows.
  • 1,000+ oncologist network with research-ready data generation during standard patient visits.
  • Prospective, consented clinical data model accelerates trial design and reduces randomization needs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Retirement Plan

Wellness Program

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

0%
Business Wire
Jan 15th, 2025
N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Based Network for Oncology Clinical Research and Clinical Trials

N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”),

HR Technology Wire
Jan 12th, 2025
N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Based Network for Oncology Clinical Research and Clinical Trials

N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. ("Syapse"), a pioneer in precision medicine solutions for community cancer centers.

FinSMEs
Jul 1st, 2024
N-Power Medicine Raises Series B Funding

N-Power Medicine, a Redwood City, CA-based company which specializes in clinical trial processes, raised an undisclosed amount in Series B funding

Recently Posted Jobs

Sign up to get curated job recommendations

N-Power Medicine is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →